Search for: "Novartis Pharmaceuticals Corporation" Results 21 - 40 of 155
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Jun 2010, 1:58 pm by Matthew Kadushin
Swiss pharmaceutical firm Novartis was found guilty of New York sexual harassment and discrimination last Monday by a jury and ordered to pay out $3.3 million to a dozen women who headed up a class action suit. [read post]
5 Oct 2010, 8:48 am by fraudfighters
Department of Justice announced that it had reached an agreement with Novartis Pharmaceuticals Corporation in which the company agreed to pay $237.5 million to settle four False Claims Act lawsuits alleging that Novartis engaged in an unlawful off-label marketing scheme in connection with its anti-epileptic drug Trileptal and wrongfully paid kickbacks to physicians to encourage them to prescribe Trileptal, as well as other Novartis drugs.  [read post]
18 Dec 2009, 9:59 am by Karen E. Keller
(patent infringement) 12/10: Seattle Children's Hospital, Novartis AG, Novartis Vaccines and Diagnostics, Inc. and Novartis Pharmaceuticals Corporation v. [read post]
30 Sep 2010, 5:03 am by Ben Vernia
Right on schedule to end the fiscal year, DOJ announced on September 30 that Novartis Pharmaceuticals Corp. has agreed to plead guilty to a misdemeanor and pay criminal and civil fines and damages. [read post]
17 Jan 2018, 1:25 pm
Novartis Pharmaceuticals Corporation, S233898).Le devoir de diligence est une des conditions centrales de l'obligation de réparer un dommage en responsabilité civile. [read post]
16 Dec 2011, 9:15 pm by Patent Docs
IBC Legal will be holding its 20th annual Biotech & Pharmaceutical Patenting conference on February 21-22, 2012 in Munich, Germany. [read post]
21 Nov 2006, 12:04 pm
Novartis Pharmaceuticals Corporation, No. 05-CV-5350, and was filed in the U.S. [read post]
13 Jan 2018, 8:00 pm
Novartis Pharmaceuticals Corporation, S233898).Responsabilité civile et contractuelle (droit californien), déclaration inexacte ("misrepresentation") :En droit californien, une action en dommages-intérêts fondée sur une déclaration inexacte peut être déposée contre d'autres défendeurs que le seul fabricant du produit. [read post]
3 Apr 2007, 2:55 pm
Novartis Suspends Sales After FDA Determines That Risks Of Serious Side Effects Outweigh Benefits Of Zelnorm (Posted by Tom Lamb at DrugInjuryWatch.com) On March 30, 2007 the FDA announced that Novartis Pharmaceuticals Corporation had suspended the marketing and sales of Zelnorm (tegaserod), a widely prescribed medication for irritable bowel syndrome (IBS) and constipation, due to an apparent increased risk of heart attacks and strokes in patients using Zelnorm.… [read post]
25 Nov 2007, 11:04 am
And the New Jersey defendants did not appear to be sham: They were Novartis Pharmaceuticals Corporation and Novartis Corporation, which presumably played a significant role in manufacturing or selling the drug that allegedy killed the plaintiffs' child.And the plaintiffs seemingly made good faith efforts to serve the complaint on Novartis Pharmaceuticals Corporation. [read post]
4 May 2010, 10:29 pm by Ben Vernia
According to DOJ’s press release: Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation have agreed to pay $72.5 million to resolve civil False Claims Act allegations arising from the marketing of the cystic fibrosis drug TOBI, the Justice Department announced today. [read post]
24 Apr 2020, 5:24 am by Lawrence B. Ebert
(collectively, Apotex) filed a petition for inter partes reviewof Novartis Pharmaceuticals Corporation’s U.S. [read post]
7 Feb 2018, 8:39 am by Clay Hodges
What’s more alarming, the drug’s manufacturer, Novartis Pharmaceuticals Corporation, may have known about those risks and failed to disclose them to you. [read post]
19 Aug 2007, 5:13 pm
Novartis Pharmaceuticals Corporation et al. v. [read post]
5 May 2013, 11:10 am
As part of the 2010 deal, Novartis signed a five-year corporate integrity agreement with the U.S. [read post]
25 Jun 2020, 12:07 pm by Mary Jane Wilmoth
Department of Justice (DOJ) announced Novartis AG (“Novartis”), a global pharmaceutical and healthcare company based in Switzerland, agreed to pay over $225 million to resolve FCPA charges for bribery in Greece. [read post]